ACRO BIOMEDICAL CO., LTD. (ACBM) Operating cash flow 2017–2025
ACRO BIOMEDICAL CO., LTD. (ACBM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$196,302FY2025 · since FY2017: -$463,344 → -$196,302
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$196,302 | -435.0% |
| FY2024 | -$36,692 | -137.6% |
| FY2023 | -$15,446 | +89.5% |
| FY2022 | -$147,481 | -149.3% |
| FY2021 | $299,335 | +250.1% |
| FY2020 | -$199,460 | -234.1% |
| FY2019 | -$59,709 | +57.5% |
| FY2018 | -$140,419 | +69.7% |
| FY2017 | -$463,344 | — |
Source: SEC XBRL filings · For reference only · Not investment advice